Latest from Product Liability Advocate - Page 2

Electric scooters and the shared economy If you have spent any time in Los Angeles or New York City recently, you may have noticed adults riding two-wheeled electric scooters − the type we are more accustomed to seeing kids ride. These scooters are the latest transportation tools in the ever-evolving sharing economy.…
By now, followers of California’s Proposition 65 are well aware of the August 30, 2018, changes. In a nutshell, they are: Changes to warnings that require inclusion of a specific chemical and potential harmful result of either cancer and/or birth defect Required website warnings Mandatory pictograph and required font size The burden is shifted from retailers to manufacturers Annual renewal and review.…
After more than five years of uncertainty, the Florida Supreme Court’s opinion in DeLisle v. Crane finally settled the debate over the standard for determining the admissibility of expert witness testimony in Florida state courts. Case No. SC16-2182 (Fla. Oct. 15, 2018). In a narrow 4-3 decision, the court rejected Daubert and adopted Frye. The outcome should come as no surprise. In 2017, in a rarely exercised move, the Florida Supreme Court declined to adopt…
The discovery phase in your products liability lawsuit has been completed and it’s time to decide the next course of action before proceeding to trial. One possibility, of course, is to move for summary judgment to knock out the entire case pending against your client. However, you have concluded that, despite the strengths of your case, there are enough “issues of fact” to make the exercise probably useless. Have you considered instead a Motion for…
The Evolution of Innovator Liability for Pharmaceutical Manufacturers Brand-name drug manufacturers are not unfamiliar with the concept of Innovator Liability, under which they can be held liable for injuries caused by a product they did not make. In other words, Innovator Liability holds a manufacturer liable by virtue of being an innovator. Innovator Liability, usually brought under a failure to warn theory, can be traced back to a 2008 California case, Conte v. Wyeth, Inc.,…
On March 16, 2018, Massachusetts’s highest court , the Supreme Judicial Court, issued a ruling that we believe will increase the product liability risk exposure for pharmaceutical manufacturers in the state. In the case of Rafferty v. Merck & Co., SJC-12347 (March 16, 2018), the Supreme Judicial Court held that a user of a generic drug may not bring a simple negligence claim against the brand-name manufacturer for failure to warn, but the user…
Every commercial airline flight carries scores of lithium-ion powered batteries in phones, tablets, computers, activity trackers, cameras, headphones and other devices. Consumers need to respect the risks that are associated with these products if not used, stored or charged correctly. Battery manufacturers and the manufacturers of products containing them must be ready to respond to all claimed incidents.…
In Tincher v. Omega Flex, Inc., 104 A. 2d 328 (Pa. 2014), the Pennsylvania Supreme Court cast aside more than 35 years of precedent when it reformulated the standards determining the circumstances under which a product is considered defective within the context of the Restatement (Second) of Torts, Section 402 (A). From the court’s decision in Azzarello v. Black Bros. Co., 391 A. 2d 1020 (Pa. 1978) until Tincher, a product defect existed if the…